deltatrials
Completed PHASE2 INTERVENTIONAL NCT00000294

Effects of Carvedilol on Cocaine Use in Humans - 11

Effects of Carvedilol on Cocaine Use in Humans

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Cocaine-Related Disorders
Interventions Carvedilol
Updated 6 times since 2017 Last updated: Jan 11, 2017 Started: Sep 30, 1998 Completion: Dec 31, 2001
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Cocaine-Related Disorders and is currently completed. National Institute on Drug Abuse (NIDA) leads this study, which shows 6 recorded versions since 1998 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Nov 2019 · 17 months · monthly snapshotCompleted~Nov 2019 – ~Jan 2021 · 14 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 21 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Nov 2019 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jun 2018 — Nov 2019 [monthly]

    Completed PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Sep 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute on Drug Abuse (NIDA)
  • University of Minnesota
Data source: National Institute on Drug Abuse (NIDA)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations